Harmony Biosciences Ownership

Harmony Biosciences Holdings has a total of 57.03 Million outstanding shares. The majority of Harmony Biosciences outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Harmony Biosciences to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Harmony Biosciences Holdings. Please pay attention to any change in the institutional holdings of Harmony Biosciences as this could imply that something significant has changed or is about to change at the company. Also note that almost two million five hundred fourty-three thousand five hundred ninety-six invesors are currently shorting Harmony Biosciences expressing very little confidence in its future performance. Some institutional investors establish a significant position in stocks such as Harmony Biosciences in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Harmony Biosciences, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. Dividend Paid And Capex Coverage Ratio is likely to rise to 738.32 in 2024, whereas Dividends Paid is likely to drop slightly above 4.3 M in 2024. Common Stock Shares Outstanding is likely to rise to about 64.3 M in 2024. Net Income Applicable To Common Shares is likely to rise to about 219.1 M in 2024. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harmony Biosciences Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.